Article on CorValen ribose study

[Guest guest]

This may have already been posted, but I thought it might be of interest.

http://www.medicalnewstoday.com/medicalnews.php?newsid=37399

CORvalenTM (D-Ribose) Improves Pain And Quality Of Life In

Fibromyalgia And Chronic Fatigue Patients

Main Category: Pain/Anesthetics News

Article Date: 09 Feb 2006 - 4:00am (UK)

Can a simple sugar provide relief for the millions of patients

afflicted with the diagnosis of fibromyalgia and/or chronic fatigue?

That's what Teitelbaum, MD, and Valen Labs wanted to determine

with an open label, 41-patient feasibility study, the results of which

are now being released.

The study had two endpoints: assessing the level of relief in symptoms

of fatigue and pain; and determining changes in patient quality of life.

The patients in the study had an average age of 48 years and were

78-percent female, which is in keeping with the general population as

fibromyalgia and chronic fatigue syndrome affect twice as many women

as men and typically first appears at middle age.

At the start of the study the patients completed a 10-point quality of

life visual analog scale and then took five grams of CORvalenTM

D-ribose orally, three times a day, for an average of 28 days.

After the 28-day treatment period the QOL questionnaire was repeated,

and 69-percent of the 36 patients who completed the course of

CORvalenTM treatment had significant improvement in their symptoms.

They also averaged a 25-percent improvement in the QOL scale.

" What this did was verify what we already knew about the impact of

ribose on energy recovery in muscles generally, " says

Teitelbaum, MD, Medical Director of the Center for Effective

CFS/Fibromyalgia Therapies in polis, land. " But specifically

we determined the energy building benefit of ribose directly improved

the debilitating symptoms of these conditions. I think this study, and

follow on studies now in development, will make ribose one of the most

important new nutrients studies in the next few years. "

Any bit of good news on the relief front - from ribose or otherwise -

will certainly be welcome by the over two million Americans who suffer

from widespread pain, sleep disturbances, fatigue, reduced exercise

tolerance, irritable bowel syndrome, anxiety, depression, headaches

and other symptoms of fibromyalgia and chronic fatigue syndrome.

" Despite the fact chronic pain syndrome with fibromyalgia-like

symptoms have been described in medical literature for over 200 years,

we still don't know the exact cause, " states Clarence , CEO of

Bioenergy and Valen Labs. " We do know however that people with

fibromyalgia have lower levels of the energy molecule called adenosine

triphosphate (ATP) and a reduced capacity to make ATP in their

muscles. We know from previous studies ribose can fuel ATP synthesis

and are gratified to see this latest piece of science showing ribose

supplementation can reduce muscle pain and enhance quality of life for

those suffering with fibromyalgia and/or chronic fatigue. "

Bioenergy, Inc., is a privately-held, Minneapolis-based life sciences

company whose core technology lies in the development and

commercialization of products based on the physiological benefits of

D-ribose in health and wellness. Bioenergy's clear mission is to

develop products that increase the quality of its customers' lives by

improving the function of their hearts, muscles, and other body

tissues. Valen Labs, Inc., its subsidiary, markets ribose-based

products to the functional food and clinical nutrition markets.

Valen's products include Bioenergy RIBOSETM, a functional ingredient

in the active lifestyle market; CORvalenTM, a clinical nutrition

product giving metabolic support to heart patients; and CORvalenMTM, a

dietary supplement that helps relieve myalgia, muscle soreness,

cramping and fatigue. For more information go to http://www.bioenergy.com.

Jennie